Curetis: Care for a healthy future




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Curetis: Care for a healthy future
Released on: December 22, 2016. © PharmaVentures Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    Curetis is not your typical biotech start-up.
  • Summary
  • Participants
Curetis is not your typical biotech start-up. They are a newcomer with many years of multi-disciplinary expertise. Over the past years they have created a healthy growth story. Curetis have convinced thier customers and partners, with our pioneering spirit, coupled with the simple aspiration "We care for Diagnostics“, our engineering prowess, and molecular biology and microbiological expertise".
Following a long-standing career with Epigenomics AG (1998–2011), Oliver Schacht, an expert in the diagnostics industry, has been CEO of Curetis since 2011. He was a co-founder and CFO of Epigenomics AG in Berlin and CEO of the US subsidiary Epigenomics Inc. (Seattle, USA). Oliver has extensive experience in developing and implementing commercial strategies and financing measures (including an IPO), as well as in finance, M&A transactions and alliance negotiations. Oliver obtained his Diploma in European Business Administration at the European School of Business in Reutlingen and London in 1994 as well as a master's degree and a PhD at the University of Cambridge (UK). During his time at Mercer Management Consulting (1995–1999), he worked on projects in the fields of M&A, growth strategies and reorganization in the pharmaceutical, biotechnology and other industries.